We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CN Bio

News List

Lonza, CN Bio Partner on Prevalidated Hepatocytes for Organ-on-a-chip Range contractpharma
July 20, 2021
Lonza will supply cells to be prequalified for use in CN Bio’s innovative PhysioMimix OOC range of Single- and Multi-Organ Microphysiological Systems.
FDA Expands Collaboration with CN Bio to Investigate Lung-On-A-Chip Model for Inhaled Drug Evaluation Applications americanpharmaceuticalreview
May 07, 2021
CN Bio, a developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, announced that the U.S. Food and Drug Administration (FDA) has extended their research collaboration ...
CN Bio, University of Melbourne collaborate to advance therapies for respiratory complications in recovered Covid-19 patients pharmaceutical-business-review
December 18, 2020
CN Bio announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.